Evaluation of plasma and urinary salbutamol levels in COPD

European Journal of Clinical Pharmacology

Volumn 51, Issue 1, 1996, Pages 91-93

  Clark, D J ^a   Tan, K S ^a   Lipworth, B J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

COPD; Nebulised; Overnight urinary salbutamol; Pharmacokinetics; Salbutamol

Indexed keywords

SALBUTAMOL;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG URINE LEVEL; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER; PRIORITY JOURNAL; URINARY EXCRETION;

ADMINISTRATION, INHALATION; AGED; ALBUTEROL; ANALYSIS OF VARIANCE; BRONCHODILATOR AGENTS; FEMALE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; TISSUE DISTRIBUTION;

EID: 0029766207     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050166     Document Type: Article

References (8)

1. Lane DG (1991) Chronic persistent asthma: nebulisers and therapy additional to inhaled β-agonists and steroids. Respir Med 5:359-363
2. Loffert DT, Ikle D, Nelson HS (1994) A comparison of commercial jet nebulisers. Chest 106: 1788-1793
3. Johnson MA, Newman SP, Bloom R, Talaee N, Clarke SW (1989) Delivery of albuterol and ipratropium bromide from two nebuliser systems in chronic stable asthma. Chest 96:6-10
4. Hultquist C, Wollmar P, Eklundh G, Jonson B (1992) Effect of inhaled terbutaline sulphate in relation to its deposition in the lungs. Pulm Pharmacol 5:127-132
5. Newnham DM, Lipworth BJ (1994) Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system (Ventstream). Thorax 49:762-770
6. Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, Clark GA et al (1989) Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 37:567-571
7. Hindle M, Chrystyn H (1992) Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmac 34:311-315
8. Hochhaus G, Mollman H (1992) Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol. Int J Clin Pharmacol Ther Toxicol 30(9):342-362